Effect of nebivolol on forearm vasodilation, nitric oxide bioavailability, and oxidative stress in patients with stage 1/2 hypertension.
Phase of Trial: Phase III
Latest Information Update: 30 Aug 2010
At a glance
- Drugs Nebivolol (Primary) ; Metoprolol
- Indications Hypertension
- Focus Biomarker; Pharmacodynamics; Registrational
- Sponsors Forest Laboratories
- 06 Jan 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 06 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.